HF Foods Group Inc. (HFFG): Nasdaq/NYSE listing notice — HF Foods receives Nasdaq non-compliance letter, granted delisting stay until Jan 31, 2023

HF Foods Group Inc.

Received Nasdaq non-compliance letter for failure to timely file Q3 2022 10-Q and other delinquent reports.
Nasdaq Hearings Panel granted extended stay of delisting proceedings until January 31, 2023.
Must provide update on independent auditors' progress by December 30, 2022.
Delinquent reports include FY 2021 10-K, Q1, Q2, and Q3 2022 10-Qs.
Delays tied to previously disclosed Special Investigation Committee and SEC investigation.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

HF Foods Group Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

10-Q for the three months ended June 30, 2022 (the “Q2 2022 Form 10-Q”, and, together with the Form 10-K, the Q1 2022 Form 10-Q and the Q2 2022 Form 10-Q, the “Delinquent Reports”), the Company is not in compliance with the timely filing requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. As previously disclosed, on September 27, 2022, the Company received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualific

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

HF Foods Group Inc. filing history →

Source: SEC EDGAR

accession 0001680873-22-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.